Evidence map›Paper›PMID 19211265›Full record

ArticleCardiovascular pathology : the official journal of the Society for Cardiovascular Pathology

Creation, validation, and quantitative analysis of protein expression in vascular tissue microarrays.

Marc K Halushka, Toby C Cornish, Jie Lu, Steve Selvin, Elizabeth Selvin

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Glomerular protein levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 are lower in diabetic subjects.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2009
    Article
  10. Use of human vascular tissue microarrays for measurement of advanced glycation endproducts.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2009
    Article
  11. Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2009
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marc K HalushkaDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. mhalush1@jhmi.edu
Toby C Cornish
Jie Lu
Steve Selvin
Elizabeth Selvin
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Glycemia Advanced Gylcation End products (AGEs) and Atherosclerosis in DiabetesK01DK076595 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SELVIN, ELIZABETH · 2006 to 2010
$606k
NIDDK NIH HHS K01 DK076595
6 · The paper itself

Abstract

backgroundTissue microarrays (TMAs) are collections of multiple tissue cores placed in parallel in a single acceptor block and traditionally used to investigate protein expression in neoplastic tissues. We validated the use of TMAs to investigate protein expression in vascular segments.

methodsVascular tissues were collected from 100 adult subjects undergoing autopsy. A diverse set of vessels were harvested and arrayed over 17 TMAs. A total of 1377 unique tissues, each with a 1.5-mm feature size, were analyzed using histochemical and immunohistochemical (IHC) diaminobenzidine (DAB) methods.

resultsHistomorphometric analysis of vascular disease demonstrated the TMA features captured the majority of the vascular alterations (intimal hyperplasia and atherosclerosis) seen in the original blood vessel section. Measurements of IHC staining intensity based on color deconvolution were used to quantify antigen abundance in defined regions of interest (ROI). Validation was performed using antibodies to connective tissue growth factor (CTGF), receptor for advanced glycation end products (AGER/RAGE), and matrix metalloproteinase 3 (MMP-3). IHC staining was highly correlated between duplicate features from the same vascular site over these three proteins.

conclusionThis study validates the use of TMA technology to investigate the vascular wall utilizing staining intensity data.

Indexed as

AutopsyBlood VesselsFemaleHumansImmunohistochemistryMaleMiddle AgedProteinsTissue Array AnalysisVascular DiseasesProteins

Identifiers

PMID19211265
PMCPMC2866781
OpenAlexW1978010386

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.